超声下甲状腺结节大小对恶性及最终病理大小的预测价值
本研究纳入659例患者共1003个切除甲状腺结节,评估超声结节大小与恶性风险及病理大小的关系。结果显示结节大小与恶性风险呈负相关,<2 cm结节恶性率最高(约30%),≥2 cm结节风险相似(约20%);超声大小对恶性预测价值差,但对最终病理大小预测较好(R2=0.748)。
要点
- 结节大小与恶性风险呈负相关,<2 cm结节恶性率最高(约30%)。
- 超声大小单独预测恶性价值差,不应作为独立危险因素。
- 超声大小与最终病理大小相关性较好(R2=0.748),但较大结节相关性下降。
核心结论
- 甲状腺结节大小与恶性风险呈负相关,较大结节恶性率较低;但大小与恶性的关系因是否行细针穿刺(FNA)而异,所有结节(无论是否行FNA)在≥2 cm处均显示风险低谷。
- 仅凭大小不应被视为独立的恶性危险因素;具有适当临床和影像学特征的病变无论大小均应行FNA,大小和FNA诊断均应影响临床决策。
研究设计与样本
- 研究纳入659例患者共1003个有术前超声的切除甲状腺结节,记录超声结节大小、FNA Bethesda分类、病理大小和最终组织学诊断,排除无法建立相关性的结节。
主要发现
- 1003个结节中26%为恶性;<2 cm结节恶性率最高(约30%),≥2 cm结节风险相似(约20%)。
- 548个行FNA的结节中38%为恶性,恶性率随大小增加而下降(<1 cm结节57%降至>6 cm结节20%)。
- 在超声大小切点2、3、4、5 cm处,较小结节比较小结节恶性率更高。
- 455个未行FNA的结节中11%为恶性。
- 超声大小单独预测恶性价值差,但预测最终病理大小相对较好(R2=0.748),较大结节相关性较低;行FNA的结节中假阴性诊断在3-6 cm结节最高(6-8%),主要因包裹性滤泡型乳头状癌。
关键数值与推荐
- 超声大小切点2、3、4、5 cm处,较小结节恶性率高于较大结节。
- 行FNA结节中,<1 cm结节恶性率57%,>6 cm结节恶性率20%。
- 超声大小与最终病理大小相关R2=0.748。
- 行FNA结节3-6 cm假阴性率6-8%。
临床怎么用
- 具有适当临床和影像学特征的病变无论大小均应行FNA。
- 大小和FNA诊断均应影响临床决策过程。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thyroid-related mortality has remained constant despite the increasing incidence of thyroid carcinoma. Most thyroid nodules are benign; therefore, ultrasound and fine needle aspiration (FNA) are integral in cancer screening. We hypothesize that increased nodule size at ultrasound does not predict malignancy and correlation between nodule size at ultrasound and pathologic exam is good. METHODS: Resected thyroids with preoperative ultrasounds were identified. Nodule size at ultrasound, FNA diagnosis by Bethesda category, size at pathologic examination, and final histologic diagnosis were recorded. Nodule characteristics at ultrasound and FNA diagnoses were correlated with gross characteristics and histologic diagnoses. Nodules for which correlation could not be established were excluded. RESULTS: Of 1003 nodules from 659 patients, 26% were malignant. Nodules <2 cm had the highest malignancy rate (∼30%). Risk was similar (∼20%) for nodules ≥2 cm. Of the 548 subject to FNA, 38% were malignant. Decreasing malignancy rates were observed with increasing size (57% for nodules <1 cm to 20% for nodules >6 cm). At ultrasound size cutoffs of 2, 3, 4, and 5 cm, smaller nodules had higher malignancy rates than larger nodules. Of the 455 not subject to FNA, 11% were malignant. Ultrasound size alone is a poor predictor of malignancy, but a relatively good predictor of final pathologic size (R2 = 0.748), with less correlation at larger sizes. In nodules subject to FNA, false negative diagnoses were highest (6-8%) in nodules 3-6 cm, mostly due to encapsulated follicular variant of papillary carcinoma. CONCLUSIONS: Thyroid nodule size is inversely related to malignancy risk, as larger nodules have lower malignancy rates. However, the relationship of size to malignancy varies by FNA status. All nodules (regardless of FNA status) demonstrate a risk trough at ≥2 cm. Nodules subject to FNA show step-wise decline in malignancy rates by size, demonstrating that size alone should not be considered as an independent risk factor. Size at ultrasound shows relatively good correlation with final pathologic size. False negative rates are low in this series. Lesions with the appropriate constellation of clinical and radiographic findings should undergo FNA regardless of size. Both size and FNA diagnosis should influence the clinical decision-making process.
引用
- Cavallo A, Johnson DN, White MG, et al. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size. Thyroid. 2017. PMID: 28052718. doi:10.1089/thy.2016.0336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。